JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141482

Myeloperoxidase Inhibitor, MPO inhibitor

Be the first to review this product! Submit a review

|

(1 Publication)

MW 151.17 Da, Purity >95%. Potent, irreversible and specific MPO inhibitor (IC50 = 300 nM). Benzoic acid analog. No inhibition of catalase or glutathione peroxidase activity. Inhibits apoptosis in vitro.

View Alternative Names

84 kDa myeloperoxidase, 89 kDa myeloperoxidase, EC 1.11.1.7, EC1.11.2.2, MPO, Myeloperoxidase, Myeloperoxidase heavy chain, Myeloperoxidase light chain, PERM_HUMAN, fj80f04, mpx, myeloid-specific peroxidase, wu:fj80f04

1 Images
Chemical Structure - Myeloperoxidase Inhibitor, MPO inhibitor (AB141482)
  • Chemical Structure

Lab

Chemical Structure - Myeloperoxidase Inhibitor, MPO inhibitor (AB141482)

2D chemical structure image of ab141482, Myeloperoxidase Inhibitor, MPO inhibitor

Key facts

CAS number

5351-17-7

Purity

>95%

Form

Solid

form

Molecular weight

151.17 Da

Molecular formula

C<sub>7</sub>H<sub>9</sub>N<sub>3</sub>O

PubChem

21450

Nature

Synthetic

Solubility

Soluble in DMSO

Biochemical name

4-Aminobenzohydrazide

Biological description

Potent, irreversible and specific MPO inhibitor (IC50 = 300 nM). Benzoic acid analog. No inhibition of catalase or glutathione peroxidase activity. Inhibits apoptosis in vitro.

Canonical smiles

C1=CC(=CC=C1C(=O)NN)N

InChi

InChI=1S/C7H9N3O/c8-6-3-1-5(2-4-6)7(11)10-9/h1-4H,8-9H2,(H,10,11)

InChiKey

WPBZMCGPFHZRHJ-UHFFFAOYSA-N

IUPAC Name

4-aminobenzohydrazide

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 1977 Myeloperoxidase Inhibitor. 1977-500 is the same size as the 500 mg size of ab141482.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Myeloperoxidase also called MPO is an enzyme that plays a critical role in the body's immune response. This protein has a mass of approximately 150 kDa and exists as a dimer composed of heavy and light polypeptide chains. Myeloperoxidase is prominently expressed in neutrophils and monocytes which are types of white blood cells important for combating infections. The enzyme catalyzes the production of hypochlorous acid and other reactive substances by utilizing hydrogen peroxide and chloride ions. These reactive substances help in neutralizing pathogens during the immune response.
Biological function summary

The generation of reactive oxygen species by myeloperoxidase is essential for microbicidal activity. Myeloperoxidase functions as part of the antimicrobial system in the phagosome which is the intracellular compartment where pathogens are degraded. This enzyme works in conjunction with other components of the immune system such as NADPH oxidase. By generating hypochlorous acid MPO contributes to the oxidative burst a rapid release of reactive oxygen species during the response to pathogens.

Pathways

Myeloperoxidase integrates into the immune defense and inflammatory pathways. In particular it is associated with the neutrophil degranulation pathway where it releases its enzymatic contents to fight off microbes. MPO also interacts with proteins involved in oxidative stress processes such as superoxide dismutase which moderates levels of reactive oxygen species in cells. These interactions ensure balance in the immune response preventing excessive tissue damage during inflammation.

Dysregulated MPO activity can contribute to the development of diseases. For instance myeloperoxidase is linked with atherosclerosis a cardiovascular condition where inflammation and oxidative stress lead to plaque formation in the arteries. It also associates with vasculitis an autoimmune disorder causing inflammation of blood vessels. Both disorders can relate to the inflammatory pathways that involve MPO and proteins like C-reactive protein which serves as a marker of inflammation. Understanding MPO's role in these conditions is important for effective therapeutic interventions.

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 7:13150 PubMed27748395

2016

Human genome-wide RNAi screen reveals host factors required for enterovirus 71 replication.

Applications

Unspecified application

Species

Unspecified reactive species

Kan Xing Wu,Patchara Phuektes,Pankaj Kumar,Germaine Yen Lin Goh,Dimitri Moreau,Vincent Tak Kwong Chow,Frederic Bard,Justin Jang Hann Chu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com